Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes
Samuelson Bannow, B. T., Walter, R. B., Gernsheimer, T. B., Garcia, D. A.Language:
english
Journal:
Journal of Thrombosis and Thrombolysis
DOI:
10.1007/s11239-017-1539-4
Date:
September, 2017
File:
PDF, 584 KB
english, 2017